Cellworks is leading Precision Medicine for Oncology through personalized cancer therapy response predictions. Using innovative genomic modeling, computational biosimulation and AI heuristics, Cellworks Therapy Response Index (TRI) accurately predicts the most efficacious therapies for patients. Cancers involve complex genomic aberrations and interactions, therefore Cellworks goes beyond the ‘one mutation, one drug’ paradigm by interpreting complete mutational downstream effects to predict accurate, actionable therapies for patients. Join the Cellworks myCare clinical trials today.